OBJECTIVE: To test the hypothesis that microvascular brain pathology is associated with late-life motor impairment. METHODS: More than 2,500 persons participating in the Religious Orders Study or the Memory and Aging Project agreed to annual motor assessment and autopsy. Brains from 850 deceased participants were assessed for microvascular pathology including microinfarcts, cerebral amyloid angiopathy, and arteriolosclerosis, and we examined their association with global motor scores proximate to death. RESULTS: Mean age at death was 88.5 years. More than 60% of cases had evidence of 1 or more microvascular pathologies and of these more than half did not have observed macroinfarcts. In separate regression models adjusted for age, sex, and education, microinfarcts and arteriolosclerosis were associated with level of motor function proximate to death (arteriolosclerosis, estimate, -0.027, SE 0.005, p < 0.001; microinfarcts, estimate, -0.017, SE 0.008, p = 0.026). These associations were not attenuated when controlling for vascular risk factors and diseases, postmortem interval, or interval from last clinical examination, and did not vary with level of cognition or presence of dementia proximate to death. When the 3 microvascular pathologies, macroinfarcts, and atherosclerosis were considered together in a single model, more severe arteriolosclerosis (estimate, -0.021, SE 0.005, p < 0.001) and macroinfarcts (estimate, -0.019, SE 0.006, p < 0.001) showed separate effects with the level of motor function proximate to death. CONCLUSIONS: Microvascular brain pathology is common in older adults and may represent an under-recognized, independent cause of late-life motor impairment.
OBJECTIVE: To test the hypothesis that microvascular brain pathology is associated with late-life motor impairment. METHODS: More than 2,500 persons participating in the Religious Orders Study or the Memory and Aging Project agreed to annual motor assessment and autopsy. Brains from 850 deceased participants were assessed for microvascular pathology including microinfarcts, cerebral amyloid angiopathy, and arteriolosclerosis, and we examined their association with global motor scores proximate to death. RESULTS: Mean age at death was 88.5 years. More than 60% of cases had evidence of 1 or more microvascular pathologies and of these more than half did not have observed macroinfarcts. In separate regression models adjusted for age, sex, and education, microinfarcts and arteriolosclerosis were associated with level of motor function proximate to death (arteriolosclerosis, estimate, -0.027, SE 0.005, p < 0.001; microinfarcts, estimate, -0.017, SE 0.008, p = 0.026). These associations were not attenuated when controlling for vascular risk factors and diseases, postmortem interval, or interval from last clinical examination, and did not vary with level of cognition or presence of dementia proximate to death. When the 3 microvascular pathologies, macroinfarcts, and atherosclerosis were considered together in a single model, more severe arteriolosclerosis (estimate, -0.021, SE 0.005, p < 0.001) and macroinfarcts (estimate, -0.019, SE 0.006, p < 0.001) showed separate effects with the level of motor function proximate to death. CONCLUSIONS:Microvascular brain pathology is common in older adults and may represent an under-recognized, independent cause of late-life motor impairment.
Authors: H Baezner; C Blahak; A Poggesi; L Pantoni; D Inzitari; H Chabriat; T Erkinjuntti; F Fazekas; J M Ferro; P Langhorne; J O'Brien; P Scheltens; M C Visser; L O Wahlund; G Waldemar; A Wallin; M G Hennerici Journal: Neurology Date: 2008-03-18 Impact factor: 9.910
Authors: Alida A Gouw; Alexandra Seewann; Wiesje M van der Flier; Frederik Barkhof; Annemieke M Rozemuller; Philip Scheltens; Jeroen J G Geurts Journal: J Neurol Neurosurg Psychiatry Date: 2010-10-09 Impact factor: 10.154
Authors: Ning Cheung; Thomas Mosley; Amirul Islam; Ryo Kawasaki; A Richey Sharrett; Ronald Klein; Laura H Coker; David S Knopman; Dean K Shibata; Diane Catellier; Tien Y Wong Journal: Brain Date: 2010-06-02 Impact factor: 13.501
Authors: Melissa E Murray; Matthew L Senjem; Ronald C Petersen; John H Hollman; Greg M Preboske; Stephen D Weigand; David S Knopman; Tanis J Ferman; Dennis W Dickson; Clifford R Jack Journal: Arch Neurol Date: 2010-11
Authors: Matthew J Delmonico; Tamara B Harris; Marjolein Visser; Seok Won Park; Molly B Conroy; Pedro Velasquez-Mieyer; Robert Boudreau; Todd M Manini; Michael Nevitt; Anne B Newman; Bret H Goodpaster Journal: Am J Clin Nutr Date: 2009-10-28 Impact factor: 7.045
Authors: M Arfan Ikram; Meike W Vernooij; Albert Hofman; Wiro J Niessen; Aad van der Lugt; Monique M B Breteler Journal: Stroke Date: 2007-11-29 Impact factor: 7.914
Authors: Aron S Buchman; Robert S Wilson; Lei Yu; Patricia A Boyle; David A Bennett; Lisa L Barnes Journal: J Gerontol A Biol Sci Med Sci Date: 2015-11-02 Impact factor: 6.053
Authors: Debra A Fleischman; Jingyun Yang; Konstantinos Arfanakis; Zoe Arvanitakis; Sue E Leurgans; Arlener D Turner; Lisa L Barnes; David A Bennett; Aron S Buchman Journal: Neurology Date: 2015-03-11 Impact factor: 9.910
Authors: Manuel M Montero-Odasso; Yanina Sarquis-Adamson; Mark Speechley; Michael J Borrie; Vladimir C Hachinski; Jennie Wells; Patricia M Riccio; Marcelo Schapira; Ervin Sejdic; Richard M Camicioli; Robert Bartha; William E McIlroy; Susan Muir-Hunter Journal: JAMA Neurol Date: 2017-07-01 Impact factor: 18.302
Authors: Aron S Buchman; Lei Yu; Robert S Wilson; Patricia A Boyle; Julie A Schneider; David A Bennett Journal: J Gerontol A Biol Sci Med Sci Date: 2014-08-18 Impact factor: 6.053
Authors: Robert J Dawe; Sue E Leurgans; Jingyun Yang; Joshua M Bennett; Jeffrey M Hausdorff; Andrew S Lim; Chris Gaiteri; David A Bennett; Aron S Buchman Journal: J Gerontol A Biol Sci Med Sci Date: 2018-04-17 Impact factor: 6.053
Authors: Eseosa T Ighodaro; Erin L Abner; David W Fardo; Ai-Ling Lin; Yuriko Katsumata; Frederick A Schmitt; Richard J Kryscio; Gregory A Jicha; Janna H Neltner; Sarah E Monsell; Walter A Kukull; Debra K Moser; Frank Appiah; Adam D Bachstetter; Linda J Van Eldik; Peter T Nelson Journal: J Cereb Blood Flow Metab Date: 2016-01-06 Impact factor: 6.200